ACE Report Cover
A network meta-analysis of osteoporotic vertebral compression fracture treatments
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
SPINE
A network meta-analysis of osteoporotic vertebral compression fracture treatments .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2016;4(14):33 PLoS One. 2015 Apr 13;10(4):e0123153
Autori che hanno contribuito

LX Chen YL Li GZ Ning Y Li QL Wu JX Guo HY Shi XB Wang Y Zhou SQ Feng

Five randomized controlled trials (RCT) with a total of 777 patients were included in this meta-analysis to analyze the efficacy of percutaneous vertebroplasty (PVP), balloon kyphoplasty (BK), and conservative treatment (CT) in elderly patients with an osteoporotic vertebral compression fracture. Visual analogue scale (VAS), the risk of all-cause discontinuation, and the incidence of new fractures were used to assess and compare the three treatments options. Pooled results demonstrated PVP to be more beneficial for pain relief, and BK correlated with lower risk of all-cause discontinuation, although additional, larger-scale studies longer duration follow-ups are needed for a more conclusive analysis.


Dettagli sul finanziamento della pubblicazione +
Finanziamento:
Non-Industry funded
Sponsor:
Applied Basic Research Programs of Science and Technology Commission of Tianjin, National Natural Science Funds of China, National Natural Science Funds of China, NSFC-RFBR and Sino-australian cooperation projects
Conflitti:
None disclosed

Rischio di pregiudizio

9,5/10

Criteri di segnalazione

19/20

Indice di fragilità

N/A

Were the search methods used to find evidence (original research) on the primary question or questions stated?

Was the search for evidence reasonably comprehensive?

Were the criteria used for deciding which studies to include in the overview reported?

Was the bias in the selection of studies avoided?

Were the criteria used for assessing the validity of the included studies reported?

Was the validity of all of the studies referred to in the text assessed with use of appropriate criteria (either in selecting the studies for inclusion or in analyzing the studies that were cited)?

Were the methods used to combine the findings of the relevant studies (to reach a conclusion) reported?

Were the findings of the relevant studies combined appropriately relative to the primary question that the overview addresses?

Were the conclusions made by the author or authors supported by the data and or analysis reported in the overview?

How would you rate the scientific quality of this evidence?

Sì = 1

Incerto = 0,5

Non rilevante = 0

No = 0

La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.

4/4

Introduction

4/4

Accessing Data

4/4

Analysing Data

4/4

Results

3/4

Discussion

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.

Perché questo studio era necessario ora?

Patients with osteoporosis, mainly the elderly, often suffer vertebral compression fractures. Common treatments for these fractures are percutaneous vertebroplasty (PVP), balloon kyphoplasty (BK), and conservative treatment (CT). Previous meta-analyses have been limited in the number comparisons that can be made between the three treatments and the number of trials included. As a result, there is an ongoing discussion surrounding comparative efficacy of these treatments. This network meta-analysis was synthesized to provide a hierarchy of the three treatments based on pain, the risk of all-cause discontinuation, and the incidence of new fractures.

Qual era la domanda di ricerca principale?

Which of the three treatments: percutaneous vertebroplasty (PVP), balloon kyphoplasty (BK), and conservative treatment (CT), is the most effective and tolerable treatment in elderly patients with osteoporotic vertebral compression fractures?

Caratteristiche dello studio +
Data Source:
Amed (1985 - July 2014), British Nursing Index (1985 - July 2014), Embase (1974 - July 2014), Pubmed (1966 - July 2014),Cochrane Central Register of Controlled Trials, Google scholar, System for Information on Grey Literature in Europe (SIGLE), the National Technical Information Service, the National Research Register (UK), and the Current Controlled Trials databases were searched for relevant studies. Reference lists were also reviewed for ignored articles.
Index Terms:
The terms "balloon kyphoplasty", "vertebroplasty", "conservative treatment", "optimum pain treatment", "optimal medical therapy", "osteoprotic", and "vertebral compression fracture" were searched.
Study Selection:
Inclusion criteria were randomized controlled trials evaluating patients with osteoporotic vertebral compression fractures who were older than 60 years of age. The trials evaluated 2 of BK, PVP, and CT and assessed outcomes for pain, the risk of all-cause discontinuation, and the incidence of new fractures. Two researchers independently selected the studies and disagreements were resolved by discussion. Debates that were unable to be resolved through discussion were consulted with a further researcher and expert. Five RCTs containing a total of 777 elderly patients with osteoporotic vertebral compression fractures were included in this study.
Data Extraction:
One review author extracted data from the included studies. The original author would be contacted for clarification on studies with missing information. The extracted data was entered into Excel by two reviewers and reviewed amongst each other. Discrepancies were resolved by going back to the original publications.
Data Synthesis:
Stata (version 12.0) software was used to compile the five RCTs in this study. Standardized mean differences (SMDs), with 95% confidence intervals (CIs) for direct comparisons and 95% credible intervals (CrI), were calculated for continuous outcomes. Dichotomous data was calculated for risk of all-cause discontinuation and incidence of new fractures. Chi-square and I-square tests were used to determine heterogeneity. Surface under the cumulative ranking probabilities (SUCRA) was used to determine the hierarchy of the three treatments.
Quali erano i risultati importanti?
  • A total of 5 randomized clinical trials were included in the network meta-analysis.
  • Direct and indirect comparisons on visual analogue scale (VAS) scores indicated greater reduction in pain with PVP (3/5 studies; p>0.0001, p=0.028, p>0.0001) and BK (1/5 studies; p<0.0001) treatments compared to CT; according to SUCRA, PVP ranked first, BK second, and CT placed third
  • Direct comparisons evaluating the risk of all-cause discontinuation were significantly lower in BK (1/5 studies; p=0.036) compared to CT; according to SUCRA, BK ranked first, PVP second, and CT was third
  • Studies assessing the incidence of new fractures (36/5 studies) demonstrated no significant differences between treatments (p=0.22, 0.769, 0.065); according to SUCRA, CT had the lowest probability of new fractures, BK in second place, and PVP ranked third
  • One study demonstrated PVP to be the suggested treatment when measured by cost-effectiveness
Che cosa devo ricordare di più?

Pooled results demonstrated that PVP may be more beneficial for pain relief, and BK may demonstrate a lower risk of all-cause discontinuation in elderly osteoporotic vertebral compression fracture patients. However, definitive conclusions cannot be made based on these findings as this study was limited by the number of available trials and the number of patients included; further studies are needed to strengthen the body of evidence from which clinical decisions can be made with regards to the management of compression fractures in the elderly.

Come influenzerà l'assistenza ai miei pazienti?

Few clinical recommendations can be made based on the results of this research. While PVP treatment showed greater beneficial outcomes for pain relief, and BK was shown to have the lowest risk of all-cause discontinuation in elderly patients with an osteoporotic vertebral compression fracture, the overall body of evidence was limited quantity and quality. Future studies with larger and more uniform patient population are needed to combat heterogeneity and longer follow-up durations in studies are needed to examine the effects of these three management options.

DISCLAIMER

Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.

0 di 4 articoli mensili GRATUITI sbloccati
Ha raggiunto il suo limite di 4 visualizzazioni di articoli gratuiti questo mese

Accesso a OrthoEvidence a soli 1,99 dollari a settimana.

Rimanga in contatto con le ultime prove. Può disdire in qualsiasi momento.
  • Valutazioni critiche dei più recenti studi randomizzati controllati ad alto impatto e delle revisioni sistematiche in ortopedia.
  • Accesso ai contenuti del podcast OrthoEvidence, tra cui collaborazioni con il Journal of Bone and Joint Surgery, interviste con chirurghi di fama internazionale e tavole rotonde su notizie e argomenti ortopedici.
  • Abbonamento a The Pulse, una newsletter bisettimanale basata sulle evidenze scientifiche, progettata per aiutarla a prendere decisioni cliniche migliori.
Upgrade
Close Dialog
Bentornato!
Ha dimenticato la password?
Inizi la sua prova gratuita oggi stesso!

Il suo account sarà affiliato a
e includerà l'accesso gratuito a OrthoEvidence


O
Ha dimenticato la password?

O
Controlli la sua e-mail

Se esiste un account con l'indirizzo e-mail fornito, le verrà inviata un'e-mail di reimpostazione della password. Se non vede l'e-mail, controlli la cartella spam o posta indesiderata.

Per ulteriore assistenza, contatti il nostro team di supporto.

Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Tradurre il Rapporto ACE

OrthoEvidence utilizza un servizio di traduzione di terze parti per rendere i contenuti accessibili in più lingue. Si prega di notare che, sebbene venga fatto ogni sforzo per garantire l'accuratezza, le traduzioni potrebbero non essere sempre perfette.

Come citare questo documento ACE Report

OrthoEvidence. A network meta-analysis of osteoporotic vertebral compression fracture treatments. OE Journal. 2016;4(14):33. Available from: https://myorthoevidence.com/AceReport/Show/a-network-meta-analysis-of-osteoporotic-vertebral-compression-fracture-treatments

Copiare la citazione
Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Funzionalità per i membri Premium

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence Premium.

Condividi questo articolo ACE Report